Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

The acquisition by Hims & Hers will offer competition to blood-drawing services such as Labcorp and Quest Diagnostics ... it will use data from the blood work — with patient identities removed ...